237 related articles for article (PubMed ID: 25661102)
1. Glioblastoma in England: 2007-2011.
Brodbelt A; Greenberg D; Winters T; Williams M; Vernon S; Collins VP;
Eur J Cancer; 2015 Mar; 51(4):533-542. PubMed ID: 25661102
[TBL] [Abstract][Full Text] [Related]
2. Glioblastoma survival is improving despite increasing incidence rates: a nationwide study between 2000 and 2013 in Finland.
Korja M; Raj R; Seppä K; Luostarinen T; Malila N; Seppälä M; Mäenpää H; Pitkäniemi J
Neuro Oncol; 2019 Feb; 21(3):370-379. PubMed ID: 30312433
[TBL] [Abstract][Full Text] [Related]
3. The outcome of patients with surgically treated meningioma in England: 1999-2013. A cancer registry data analysis.
Brodbelt AR; Barclay ME; Greenberg D; Williams M; Jenkinson MD; Karabatsou K
Br J Neurosurg; 2019 Dec; 33(6):641-647. PubMed ID: 31526136
[No Abstract] [Full Text] [Related]
4. Brain Tumours: Rise in Glioblastoma Multiforme Incidence in England 1995-2015 Suggests an Adverse Environmental or Lifestyle Factor.
Philips A; Henshaw DL; Lamburn G; O'Carroll MJ
J Environ Public Health; 2018; 2018():7910754. PubMed ID: 30034480
[TBL] [Abstract][Full Text] [Related]
5. Changing incidence and improved survival of gliomas.
Ho VK; Reijneveld JC; Enting RH; Bienfait HP; Robe P; Baumert BG; Visser O;
Eur J Cancer; 2014 Sep; 50(13):2309-18. PubMed ID: 24972545
[TBL] [Abstract][Full Text] [Related]
6. Comparative epidemiology of gliosarcoma and glioblastoma and the impact of Race on overall survival: A systematic literature review.
Gerges C; Elder T; Penuela M; Rossetti N; Maynard M; Jeong S; Wright CH; Wright J; Zhou X; Burant C; Sajatovic M; Hodges T
Clin Neurol Neurosurg; 2020 Aug; 195():106054. PubMed ID: 32650210
[TBL] [Abstract][Full Text] [Related]
7. Implant volume as a prognostic variable in brachytherapy decision-making for malignant gliomas stratified by the RTOG recursive partitioning analysis.
Videtic GM; Gaspar LE; Zamorano L; Stitt LW; Fontanesi J; Levin KJ
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):963-8. PubMed ID: 11704318
[TBL] [Abstract][Full Text] [Related]
8. Prior malignancies in patients harboring glioblastoma: an institutional case-study of 2164 patients.
Zacharia BE; DiStefano N; Mader MM; Chohan MO; Ogilvie S; Brennan C; Gutin P; Tabar V
J Neurooncol; 2017 Sep; 134(2):245-251. PubMed ID: 28551847
[TBL] [Abstract][Full Text] [Related]
9. Epidemiologic and molecular prognostic review of glioblastoma.
Thakkar JP; Dolecek TA; Horbinski C; Ostrom QT; Lightner DD; Barnholtz-Sloan JS; Villano JL
Cancer Epidemiol Biomarkers Prev; 2014 Oct; 23(10):1985-96. PubMed ID: 25053711
[TBL] [Abstract][Full Text] [Related]
10. Glioblastoma multiforme (GBM) in the elderly: initial treatment strategy and overall survival.
Glaser SM; Dohopolski MJ; Balasubramani GK; Flickinger JC; Beriwal S
J Neurooncol; 2017 Aug; 134(1):107-118. PubMed ID: 28527010
[TBL] [Abstract][Full Text] [Related]
11. Survival Analysis of Glioblastoma Multiforme.
Witthayanuwat S; Pesee M; Supaadirek C; Supakalin N; Thamronganantasakul K; Krusun S
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2613-2617. PubMed ID: 30256068
[TBL] [Abstract][Full Text] [Related]
12. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
[TBL] [Abstract][Full Text] [Related]
13. Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.
Weller M; Butowski N; Tran DD; Recht LD; Lim M; Hirte H; Ashby L; Mechtler L; Goldlust SA; Iwamoto F; Drappatz J; O'Rourke DM; Wong M; Hamilton MG; Finocchiaro G; Perry J; Wick W; Green J; He Y; Turner CD; Yellin MJ; Keler T; Davis TA; Stupp R; Sampson JH;
Lancet Oncol; 2017 Oct; 18(10):1373-1385. PubMed ID: 28844499
[TBL] [Abstract][Full Text] [Related]
14. Glioblastoma multiforme outcomes of 107 patients treated in two Singapore institutions.
Cheo ST; Lim GH; Lim KH
Singapore Med J; 2017 Jan; 58(1):41-45. PubMed ID: 26915391
[TBL] [Abstract][Full Text] [Related]
15. Glioblastoma in adolescents and young adults: An age-based comparative study from Jordan over a 17-year period.
Alhalaseh YN; Abdulelah ZA; Abu-Shanab A; Armouti AO; Amarin JZ; Mansour R; Sultan H; Al-Hussaini M
Cancer Epidemiol; 2021 Aug; 73():101948. PubMed ID: 33975256
[TBL] [Abstract][Full Text] [Related]
16. A population-based description of glioblastoma multiforme in Los Angeles County, 1974-1999.
Chakrabarti I; Cockburn M; Cozen W; Wang YP; Preston-Martin S
Cancer; 2005 Dec; 104(12):2798-806. PubMed ID: 16288487
[TBL] [Abstract][Full Text] [Related]
17. Treatment and survival of glioblastoma patients in Denmark: The Danish Neuro-Oncology Registry 2009-2014.
Hansen S; Rasmussen BK; Laursen RJ; Kosteljanetz M; Schultz H; Nørgård BM; Guldberg R; Gradel KO
J Neurooncol; 2018 Sep; 139(2):479-489. PubMed ID: 29754199
[TBL] [Abstract][Full Text] [Related]
18. Glioblastoma treatment in the elderly in the temozolomide therapy era.
Coate L; McNamara MG; Lwin Z; Macfadden D; Al-Zahrani A; Massey C; Menard C; Millar BA; Sahgal A; Laperriere N; Mason WP
Can J Neurol Sci; 2014 May; 41(3):357-62. PubMed ID: 24718821
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Time Series Forecasting and Updates on Survival Analysis of Glioblastoma Multiforme: A 1975-2018 Population-Based Study.
Alexopoulos G; Zhang J; Karampelas I; Patel M; Kemp J; Coppens J; Mattei TA; Mercier P
Neuroepidemiology; 2022; 56(2):75-89. PubMed ID: 35172317
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.
Reulen HJ; Poepperl G; Goetz C; Gildehaus FJ; Schmidt M; Tatsch K; Pietsch T; Kraus T; Rachinger W
J Neurosurg; 2015 Sep; 123(3):760-70. PubMed ID: 26140493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
